DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: Patient Advocacy

June 28, 2023
Non-English- Speaking Patients With Cancer Face Big Barriers to Care in the U.S., But Help Is Available

Patients who don't speak English face additional obstacles during their cancer journey but family, caregivers and the law are on their side.

Read More
April 26, 2023
Submit Comments on use of Placebos in Clinical Trials

The FDA is drafting new guidance on the use of external data in lieu of placebos in clinical trials. Please support this change.

Read More
June 13, 2019
Hopeless to Hope Initiative

EBCI is launching an initiative to bring more clinical trials of brain cancer treatments to the greater Puget Sound area, and to recruit and place qualified patients.

Read More
April 3, 2019
Patients, Survivors, Friends, and Partners Celebrate The EndBrainCancer Initiative’s GBM Patient & TOGETHER Day

The EndBrainCancer Initiative Initiative recently hosted its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington

Read More
March 14, 2019
GBM Patient & TOGETHER Day to Honor and Uplift Brain Cancer Patients on Friday, March 15th

The EndBrainCancer Initiative is hosting its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington. Current and past brain cancer patients, survivors, caregivers, and families are invited to this special event

Read More
August 8, 2018
The EndBrainCancer Initiative Receives CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site

The EndBrainCancer Initiative received CITI certification to recruit caregivers to participate in brain cancer caregiver and patient clinical trials at the Pacific Neuroscience Institute and John Wayne Cancer Institute in conjunction with Providence Health Services of Southern California.

Read More
February 21, 2018
Effecting Change in Glioblastoma – CURE Magazine Article by Dellann Elliott Mydland

This article describes the potential for a significant shift in current standard of care. This includes discussions related to prior consent, immunotherapy, vaccines, devices, DNA sequencing/genomic profiling, MGMT testing and so on. It also includes discussions related to advanced treatments, targeted therapies and/or clinical trials prior to surgery.

Read More
July 28, 2017
Senator McCain: Optimism, Education & Hope

Our collective awareness of this dreaded disease was heightened last week with the announcement that Senator John McCain will now be counted among the brave GBM warriors.

Read More
June 13, 2017
Reflections From ASCO Annual Meeting

Celebrating the courage, grace, and selflessness of patients everywhere who battle cancer and participate in clinical trials. The wall was filled with notes from providers, families, and advocates.

Read More
October 3, 2016
End Brain Cancer: Making Life-Saving Connections

It is time to take the politics out of brain cancer research, and for a good reason: to produce more survivors of the disease.

Read More
August 23, 2015
Impact Since 2002

From the day it was founded in 2002, the EndBrainCancer Initiative | Chris Elliott Fund has been dedicated to changing how brain cancer is treated and to offering HOPE to brain cancer patients.

Read More
August 7, 2015
EBC Initiative Slides

Gallery of slides detailing the strategy and priorities of the End Brain Cancer Initiative.

Read More

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram